Fos expression associated with the discriminative stimulus effects of methamphetamine in rats

被引:5
|
作者
Zeng, N
Nakajima, A
He, J
Nitta, A
Yamada, K
Nabeshima, T [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol, Showa Ku, Nagoya, Aichi 4668560, Japan
[2] Nagoya Univ, Grad Sch Med, Hosp Pharm, Showa Ku, Nagoya, Aichi 4668560, Japan
关键词
drug dependence; drug discrimination; c-Fos; methamphetamine; nucleus accumbens; ventral tegmental area;
D O I
10.1196/annals.1316.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methamphetamine, a psychostimulant drug, produces both acute psychomotor stimulation and long-lasting behavioral effects including addiction and psychosis. To identify anatomical substrates for the discriminative stimulus effects of methamphetamine in rats, we examined the drug discrimination-associated c-Fos expression in the brains of rats that were trained to discriminate methamphetamine from saline under a two-lever fixed ratio (FR-20) schedule of food reinforcement. c-Fos expression in the brains of rats trained to discriminate methamphetamine from saline was significantly increased in the nucleus accumbens (NAc) and the ventral tegmental area (VTA) as compared with the expression in the control rats that were maintained under the FR-20 schedule, but no alternation was observed in other areas including the cerebral cortex, caudate putamen, substantia nigra, hippocampus, amygdala, and habenulla. Methamphetamine treatment in the trained rats caused a significant increase in c-Fos expression in the VTA, and a decrease in the NAc core, as compared to saline treatment. However, c-Fos expression in the NAc and VTA of rats that received chronic intermittent methamphetamine administration without discrimination training, did not differ from the expression in saline-treatment animals. These results suggest that the VTA and the NAc play an important role in the discriminative stimulus effects of methamphetamine.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 50 条
  • [1] Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats
    Nakajima, A
    Yamada, K
    He, J
    Zeng, N
    Nitta, A
    Nabeshima, T
    JOURNAL OF NEUROCHEMISTRY, 2004, 91 (02) : 308 - 317
  • [2] Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats
    Suzuki, T
    Fukuoka, Y
    Mori, T
    Miyatake, M
    Narita, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 498 (1-3) : 157 - 161
  • [3] Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats
    Gasior, M
    Witkin, JM
    Goldberg, SR
    Munzar, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 183 - 189
  • [4] Discriminative stimulus effects of methamphetamine and in vivo microdialys,is in rats
    Desai, R. I.
    Paronis, C. A.
    Makriyannis, A.
    Thakur, G. A.
    Bergman, J.
    FASEB JOURNAL, 2007, 21 (06): : A776 - A776
  • [5] Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats
    P. Munzar
    S. R. Goldberg
    Psychopharmacology, 2000, 148 : 209 - 216
  • [6] Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats
    Munzar, P
    Goldberg, SR
    PSYCHOPHARMACOLOGY, 1999, 143 (03) : 293 - 301
  • [7] Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats
    Patrik Munzar
    S. R. Goldberg
    Psychopharmacology, 1999, 143 : 293 - 301
  • [8] Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats
    Munzar, P
    Justinova, Z
    Kutkat, SW
    Ferré, S
    Goldberg, SR
    PSYCHOPHARMACOLOGY, 2002, 161 (04) : 348 - 355
  • [9] Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats
    Munzar, P
    Goldberg, SR
    PSYCHOPHARMACOLOGY, 2000, 148 (02) : 209 - 216
  • [10] Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats
    Patrik Munzar
    Zuzana Justinova
    Scott W. Kutkat
    Sergi Ferré
    Steven R. Goldberg
    Psychopharmacology, 2002, 161 : 348 - 355